Shareholder presentation25 Jan 2024 18:32
Shareholder presentation and Q&A
CEO, Stuart Ashman, and CFO, Manprit Randhawa, will provide a live presentation about the terms and rationale of the acquisition of Dermatonics and the financing details via the Investor Meet platform Friday 26 January at 10:00 am GMT.
In addition to the overpriced acquistion - they will no doubt have their rationale - i await with interest their comments and justification - i"m struggling to find any re price to be paid
and perhaps the undernoted could also be raised
Total Remuneration
SA £60154 300619
SA £276294 300620
SA £372,718 300621
SA £368,449 300622 MR £14,951
SA £382,478 300623 MR £261,480
and also
SA appointed 18/04/19 Shares in issue 128,083,494 SP c18p
Now (but before todays rns re further increase in no of shares issued) Shares in issue 190,362,941 SP 12.75
mol